Janet Woodcock
The legislation is pretty groundbreaking. The FD&C Act up until now has been practically silent, except for some of the...
The Implementer: How the Official Who Will Make FDAAA Work Views the New Law
Listen to this article
The FDA Amendments Act transforms the drug safety system. In a recent address to the Food & Drug Law Institute, the acting head of the Center for Drug Evaluation & Research offered her view about what the law means and how the agency will make it work
Learn what's happening at the US FDA. On the go.
More from Clinical Trials
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
• By
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.
• By
Contract research organizations (CROs) in India must gear up to comply with new registration requirements coming into effect in April 2025 that aim to enhance the quality and integrity of clinical trials, as well as of any bioavailability and bioequivalence studies conducted by them.
More from R&D
• By
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.
• By
Contract research organizations (CROs) in India must gear up to comply with new registration requirements coming into effect in April 2025 that aim to enhance the quality and integrity of clinical trials, as well as of any bioavailability and bioequivalence studies conducted by them.
• By
The agency also should explain the potential consequences for sponsors if enrollment goals are not met, stakeholders say in comments on the DAP draft guidance. Some commenters urged the FDA to apply waiver criteria flexibly, especially for rare diseases.